{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2014"],"data_sharing_plan":["IPD Sharing (as of May 2023): Yes\nDescription: Study Protocol Statistical Analysis Plan (SAP) Informed Consent Form (ICF) will be shared with other researchers on request\nTime frame: 1 year after completion of study until 5 years after archiving\nAdditional information available: Study Protocol, Statistical Analysis Plan, Informed Consent Form"],"condition":["Gastrointestinal Neoplasms","All gastrointestinal and hepatobiliary cancers including colorectal cancer, cancer of unknown primary, pancreatic cancer, stomach cancer and oesophageal cancer.","Neoplasms, Unknown Primary","Gastrointestinal Cancer","Bile Duct Neoplasms","Pancreatic Cancer","Cancer of Unknown Primary Site"],"disease":["Cancer Of Unknown Primary Site","Gastrointestinal Neoplasms","Neoplasms, Unknown Primary","Gastrointestinal Cancer","Bile Duct Neoplasms","All Gastrointestinal And Hepatobiliary Cancers Including Colorectal Cancer, Cancer Of Unknown Primary, Pancreatic Cancer, Stomach Cancer And Oesophageal Cancer.","Pancreatic Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2144179"],"location":["United Kingdom"],"study_start_month":["2"],"keyword":["Capecitabine","Tegafur","Teysuno"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine","description":"Capecitabine is a chemotherapy drug used to treat many types of cancer including bowel and stomach cancer. Unfortunately a side effect of this drug is that it causes heart problems including heart attacks. An alternative drug, called teysuno is used extensively in other countries instead of capecitabine and appears to have less of a bad effect on the heart whilst still killing cancer cells. This study will investigate the effect of these two drugs on the heart and blood vessels and will be the first of its kind in humans.","dates":{"creation":"2014-02-15"},"accession":"2144179","cross_references":{"ClinicalTrials___gov":["NCT01845337"],"EU Clinical Trials Register":["2012-005282-12"]}}